Laser-engineered Dissolving Microneedle Arrays for Protein Delivery: Potential for Enhanced Intradermal Vaccination

Overview

Journal J Pharm Pharmacol

Publisher Oxford University Press

Specialties Pharmacology
Pharmacy

Date 2014 Mar 29

PMID 24673568

Citations 18

Authors

Maeliosa T C McCrudden

Barbara M Torrisi

Sharifah Al-Zahrani

Cian M McCrudden

Marija Zaric

Christopher J Scott

Adrien Kissenpfennig

Helen O McCarthy

Ryan F Donnelly

Affiliations

Soon will be listed here.

Abstract

Objectives: We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains the most accepted and effective approach in offering protection from infectious diseases. In recent years, much interest has focused on the possibility of using minimally invasive MN technologies to replace conventional hypodermic vaccine injections.

Methods: The focus of this study was exploitation of dissolving MN array devices fabricated from 20% w/w poly(methyl vinyl ether/maleic acid) using a micromoulding technique, for the facilitated delivery of a model antigen, ovalbumin (OVA).

Key Findings: A series of in-vitro and in-vivo experiments were designed to demonstrate that MN arrays loaded with OVA penetrated the stratum corneum and delivered their payload systemically. The latter was evidenced by the activation of both humoral and cellular inflammatory responses in mice, indicated by the production of immunoglobulins (IgG, IgG1, IgG2a) and inflammatory cytokines, specifically interferon-gamma and interleukin-4. Importantly, the structural integrity of the OVA following incorporation into the MN arrays was maintained.

Conclusion: While enhanced manufacturing strategies are required to improve delivery efficiency and reduce waste, dissolving MN are a promising candidate for 'reduced-risk' vaccination and protein delivery strategies.

Citing Articles

Microneedle and Polymeric Films: Delivery of Proteins, Peptides and Nucleic Acids.

Wu Y, Hutton A, Pandya A, Patravale V, Donnelly R Handb Exp Pharmacol. 2023; 284:93-111.

PMID: 37106150 DOI: 10.1007/164_2023_653.

Enhancement of Immune Responses Elicited by Nanovaccines through a Cross-Presentation Pathway.

Kim C, Lee J, Ju D, Kim S, Yun C, Cho C Tissue Eng Regen Med. 2023; 20(3):355-370.

PMID: 36884197 PMC: 9994410. DOI: 10.1007/s13770-023-00527-y.

A microarray patch SARS-CoV-2 vaccine induces sustained antibody responses and polyfunctional cellular immunity.

Balmert S, Gholizadeh Ghozloujeh Z, Donahue Carey C, Williams L, Zhang J, Shahi P iScience. 2022; 25(10):105045.

PMID: 36062075 PMC: 9425707. DOI: 10.1016/j.isci.2022.105045.

Rapidly dissolving bilayer microneedles enabling minimally invasive and efficient protein delivery to the posterior segment of the eye.

Wu Y, Vora L, Donnelly R, Raghu Raj Singh T Drug Deliv Transl Res. 2022; 13(8):2142-2158.

PMID: 35713782 PMC: 10315354. DOI: 10.1007/s13346-022-01190-x.

Dermal Microvascular Units in Domestic Pigs (): Role as Transdermal Passive Immune Channels.

Meng X, Zhu Z, Ahmed N, Ma Q, Wang Q, Deng B Front Vet Sci. 2022; 9:891286.

PMID: 35548054 PMC: 9083201. DOI: 10.3389/fvets.2022.891286.

References

Stubgen J . A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev. 2013; 13(1):31-9. DOI: 10.1016/j.autrev.2013.08.005. View

Sun W, Araci Z, Inayathullah M, Manickam S, Zhang X, Bruce M . Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications. Acta Biomater. 2013; 9(8):7767-74. PMC: 3800147. DOI: 10.1016/j.actbio.2013.04.045. View

Wegmann M . Animal models of chronic experimental asthma - strategies for the identification of new therapeutic targets. J Occup Med Toxicol. 2008; 3 Suppl 1:S4. PMC: 2259398. DOI: 10.1186/1745-6673-3-S1-S4. View

Liu S, Jin M, Quan Y, Kamiyama F, Katsumi H, Sakane T . The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Control Release. 2012; 161(3):933-41. DOI: 10.1016/j.jconrel.2012.05.030. View

de Souza Reboucas J, Irache J, Camacho A, Esparza I, Del Pozo V, Sanz M . Development of poly(anhydride) nanoparticles loaded with peanut proteins: the influence of preparation method on the immunogenic properties. Eur J Pharm Biopharm. 2012; 82(2):241-9. DOI: 10.1016/j.ejpb.2012.06.014. View

Bal S, Ding Z, van Riet E, Jiskoot W, Bouwstra J . Advances in transcutaneous vaccine delivery: do all ways lead to Rome?. J Control Release. 2010; 148(3):266-82. DOI: 10.1016/j.jconrel.2010.09.018. View

Kommareddy S, Baudner B, Oh S, Kwon S, Singh M, OHagan D . Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci. 2011; 101(3):1021-7. DOI: 10.1002/jps.23019. View

Donnelly R, Morrow D, Singh T, Migalska K, McCarron P, OMahony C . Processing difficulties and instability of carbohydrate microneedle arrays. Drug Dev Ind Pharm. 2009; 35(10):1242-54. PMC: 2900182. DOI: 10.1080/03639040902882280. View

Beisson F, Aoubala M, Marull S, Voultoury R, Verger R, Arondel V . Use of the tape stripping technique for directly quantifying esterase activities in human stratum corneum. Anal Biochem. 2001; 290(2):179-85. DOI: 10.1006/abio.2000.4977. View

10.

Donnelly R, Majithiya R, Raghu Raj Singh T, Morrow D, Garland M, Demir Y . Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res. 2010; 28(1):41-57. PMC: 3016610. DOI: 10.1007/s11095-010-0169-8. View

11.

Ito Y, Nakahigashi T, Yoshimoto N, Ueda Y, Hamasaki N, Takada K . Transdermal insulin application system with dissolving microneedles. Diabetes Technol Ther. 2012; 14(10):891-9. DOI: 10.1089/dia.2012.0096. View

12.

Naito S, Ito Y, Kiyohara T, Kataoka M, Ochiai M, Takada K . Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination. Vaccine. 2011; 30(6):1191-7. DOI: 10.1016/j.vaccine.2011.11.111. View

13.

Donnelly R, Morrow D, Fay F, Scott C, Abdelghany S, Thakur Singh R . Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers. Photodiagnosis Photodyn Ther. 2010; 7(4):222-31. DOI: 10.1016/j.pdpdt.2010.09.001. View

14.

Donnelly R, Garland M, Morrow D, Migalska K, Raghu Raj Singh T, Majithiya R . Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J Control Release. 2010; 147(3):333-41. DOI: 10.1016/j.jconrel.2010.08.008. View

15.

Smits E, Ponsaerts P, Berneman Z, Van Tendeloo V . The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist. 2008; 13(8):859-75. DOI: 10.1634/theoncologist.2008-0097. View

16.

Ballin N, Lametsch R . Analytical methods for authentication of fresh vs. thawed meat - A review. Meat Sci. 2011; 80(2):151-8. DOI: 10.1016/j.meatsci.2007.12.024. View

17.

Bouchard M, Zurdo J, Nettleton E, Dobson C, Robinson C . Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 2000; 9(10):1960-7. PMC: 2144465. DOI: 10.1110/ps.9.10.1960. View

18.

Romani N, Thurnher M, Idoyaga J, Steinman R, Flacher V . Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy. Immunol Cell Biol. 2010; 88(4):424-30. PMC: 2907485. DOI: 10.1038/icb.2010.39. View

19.

Sullivan S, Murthy N, Prausnitz M . Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater. 2012; 20(5):933-938. PMC: 3519393. DOI: 10.1002/adma.200701205. View

20.

Vermeulen M, Giordano M, Trevani A, Sedlik C, Gamberale R, Fernandez-Calotti P . Acidosis improves uptake of antigens and MHC class I-restricted presentation by dendritic cells. J Immunol. 2004; 172(5):3196-204. DOI: 10.4049/jimmunol.172.5.3196. View